Store vials sealed in an airtight container, ideally with a desiccant pack, and let a cold vial warm to room temperature before opening so condensation doesn't form inside
In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them
When your body has enough B12, you can generate healthy blood cells and maintain proper energy levels
Discussion In this study, we focused exclusively on FDA- and EMA-approved liposomal drug formulations currently on the market (five for passive loading systems, including Arikayce Kit, Visudyne, AmBisome, Mepact, and Exparel, and four for active loading systems, including Doxil, Myocet, Onivyde, and Vyxeos)
